Publication date: May 21, 2025
Population-based data are needed to reliably assess the impact of SARS-CoV-2 infection during pregnancy. To estimate the population-based incidence of SARS-CoV-2 infection and its severe forms in the obstetric population, identify risk factors of severe SARS-CoV-2 infection (severe COVID-19) and describe delivery, maternal and neonatal outcomes by disease severity, using a definition of severity based on organ dysfunction. A prospective population-based study conducted over the three first pandemic waves between March 2020 and April 2021 in 281 maternity hospitals in six French regions included all women with SARS-CoV-2 infection during pregnancy or within 7 days post-partum, whether symptomatic or not, hospitalised or not. Severe COVID-19 forms were defined a priori using clinical, biological and management criteria of organ dysfunction. We calculated infection and severe infection rates and studied associations between sociodemographic, medical and pregnancy characteristics and severe COVID-19 by univariate and multivariate modified Poisson regression modelling. From a population of 385,214 deliveries in the participating regions, 6015 women with SARS-CoV-2 infection were identified, including 337 severe cases. The rates of severe COVID-19 were 1. 1, 0. 9 and 3. 6 per 1000 deliveries during the first, second and third pandemic waves, respectively, and the proportions of severe COVID-19 were 8. 6%, 3. 4% and 9. 3%, respectively. On multivariate analysis, the risk of severe COVID-19 was associated with younger and older age, migrant status, living with > 4 people, overweight or obesity, chronic hypertension or diabetes and infection ≥ 22 weeks of gestation rather than earlier in pregnancy. Neonatal morbidity occurred mostly with severe maternal infection. Using an organ-based definition of severity and population-based data, rates of severe COVID-19 appeared lower than in previous studies. A permanent perinatal surveillance system is needed to assess efficiently and rapidly the impact of future pandemics.
Concepts | Keywords |
---|---|
April | COVID‐19 |
Diabetes | maternal morbidity |
French | neonatal morbidity |
Maternity | pregnancy |
Organ | risk factors |
SARS‐CoV‐2 |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | SARS-CoV-2 Infection |
pathway | REACTOME | SARS-CoV-2 Infection |
disease | MESH | infection |
disease | MESH | overweight |
disease | MESH | obesity |
disease | MESH | hypertension |
disease | MESH | morbidity |
disease | MESH | Long Covid |